Nona Biosciences Develops AI Model for Human Antibodies
Waltham, Massachusetts, USA, September 17, 2026 Nona Biosciences has announced the successful development of what it describes as the...
COPD
Advertisement
SMSbiotech Advances COPD Program With FDA IND Clearance
United States, September 17, 2026 SMSbiotech has announced that the U.S. Food and Drug Administration (FDA) has cleared its...
ENA Respiratory Advances INNA-051 Into Part B Phase IIa
MELBOURNE, Australia — September 15, 2026 ENA Respiratory announced that the first participants have been dosed in Part B...
Connect Biopharma Advances Rademikibart Toward Phase 3
SAN DIEGO, Calif. — September 15, 2026 Connect Biopharma Holdings Limited announced positive preliminary topline results from the global...
Upstream Bio Advances Verekitug Toward Phase 3 in Asthma
WALTHAM, Mass. — September 8, 2026 Upstream Bio, Inc. presented results from the Phase 2 VALIANT trial of verekitug...
Advertisements
Mabwell Reports 9MW1911 COPD Phase Ib/IIa Results
Shanghai, China, September 4, 2026 Mabwell (Shanghai) Bioscience Co., Ltd. has announced Phase Ib/IIa clinical results for its investigational...
Evinova and Lothar Medical Partner to Modernize Respiratory Trials
Baar, Switzerland — September 5, 2026 Evinova announced a strategic partnership with Lothar Medical to modernize the execution of...
Ernexa Therapeutics Advances ERNA-101 Toward Phase 1 Trial
Cambridge, Massachusetts, August 10, 2026 Ernexa Therapeutics announced the appointment of David Polinsky to its Board of Directors as...
Genome BC Advances Genomic Health Research in British Columbia
Vancouver, British Columbia, August 11, 2026 Genome BC has announced six research projects supported through its Data Access, Integration...
bioAffinity Technologies Reports CyPath Lung Growth
SAN ANTONIO, Texas, August 7, 2026 bioAffinity Technologies reported second quarter 2026 financial results highlighted by continued commercial momentum...
Advertisement
